Skip to content
10-Q

Quarterly Report

COMPLETE GENOMICS INC

0001193125-12-221876

← back to feed
Filed
May 9, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 30, 2012 33.89M sh
Capex Q1 2012 · Mar 31, 2012 $4.8M
Capex Q1 2012 · Mar 31, 2011 $2.87M
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$15.36M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$8.9M
Short Term Investments Q1 2012 · Mar 31, 2012 $16M
Short Term Investments Q1 2012 · Dec 31, 2011 $6M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $47.12M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $77.07M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $68.79M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $68.92M
Stockholders Equity Q1 2012 · Mar 31, 2012 $64.44M
Stockholders Equity Q1 2012 · Dec 31, 2011 $82.61M
Current Liabilities Q1 2012 · Mar 31, 2012 $45.5M
Current Liabilities Q1 2012 · Dec 31, 2011 $27.89M
Total Liabilities Q1 2012 · Mar 31, 2012 $48.83M
Total Liabilities Q1 2012 · Dec 31, 2011 $47.59M
Current Assets Q1 2012 · Mar 31, 2012 $77.86M
Current Assets Q1 2012 · Dec 31, 2011 $95.17M
Total Assets Q1 2012 · Mar 31, 2012 $113.27M
Total Assets Q1 2012 · Dec 31, 2011 $130.2M
Sga Expense Q1 2012 · Mar 31, 2012 $4.14M
Sga Expense Q1 2012 · Mar 31, 2011 $2.78M
Rd Expense Q1 2012 · Mar 31, 2012 $8.69M
Rd Expense Q1 2012 · Mar 31, 2011 $6.81M
Net Income Q1 2012 · Mar 31, 2012 −$20.23M
Net Income Q1 2012 · Mar 31, 2011 −$12.46M
Operating Income Q1 2012 · Mar 31, 2012 −$19.47M
Operating Income Q1 2012 · Mar 31, 2011 −$12.04M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $5.3M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $6.58M
Revenue Q1 2012 · Mar 31, 2012 $3.91M
Revenue Q1 2012 · Mar 31, 2011 $6.83M